Body Mass Index and Risk of Post‑Treatment Relapse in Endometrial Cancer: Evidence from an Iraqi Cross‑Sectional Cohort
- Authors
-
-
Zainab Mohamed Alaa Alhelli
Sadr Oncology Center, Baghdad, Iraq -
Amaal Mohammed Alhelli
Department of Water Resource Technique, Institute of Technology, Middle Technical University, Alzafaranya, Baghdad 29008, Iraq -
Aadil S Aqabi
Medical City Blood Disease & Transplant Center, Baghdad, Iraq
-
- Keywords:
- Endometrial Cancer, Obesity, Body Mass Index, Relapse, Prognostic Marker
- Abstract
-
Obesity has been identified as a contributing factor to the development and outcomes of endometrial cancer (EC), yet its role in post-treatment relapse remains to be elucidated. The objective of this study is to examine the association between body mass index (BMI) and the incidence of relapse among Iraqi women diagnosed with endometrial cancer (EC). A cross-sectional study was conducted at the Oncology Teaching Hospital, Baghdad Medical City (January–October 2021). A total of 75 women with histologically confirmed EC were categorized by BMI (normal weight, overweight, obese) according to the WHO criteria. Relapse was ascertained during routine follow-up and compared across BMI categories using chi-square testing. The discriminatory performance of continuous BMI was assessed using receiver operating characteristic (ROC) analysis. The results indicated that relapse occurred in 24% of normal-weight patients, 32% of overweight patients, and 60% of obese patients (χ² = 7.17; p = 0.027). The BMI exhibited moderate discriminatory capability for relapse (AUC=0.638; 95% CI 0.505–0.771; p=0.045), with an optimal threshold of 26.9 kg/m² (sensitivity 72%, specificity 48%). A higher BMI has been demonstrated to be associated with an increased risk of relapse following EC treatment. Given its modest discriminatory performance, BMI should not be considered a stand-alone prognostic marker. However, it may provide supportive information in low-resource settings. The validation of these findings in larger, multivariable studies is warranted.
- References
-
Allott, E. H., & Hursting, S. D. (2015). Obesity and cancer: mechanistic insights from transdisciplinary studies. Endocrine-Related Cancer, 22(6), R365–R386. https://doi.org/10.1530/ERC-15-0400
Arem, H., & Irwin, M. L. (2013). Obesity and endometrial cancer survival: a systematic review. International Journal of Obesity, 37(5), 634–639. https://doi.org/10.1038/ijo.2012.94
Burkett, W. C., Clontz, A. D., Keku, T. O., & Bae-Jump, V. (2023). The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1878(6), 189000. https://doi.org/10.1016/j.bbcan.2023.189000
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003). Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults. New England Journal of Medicine, 348(17), 1625–1638. https://doi.org/10.1056/NEJMoa021423
Clark, L. H., Ko, E. M., Kernodle, A., Harris, A., Moore, D. T., Gehrig, P. A., & Bae-Jump, V. (2016). Endometrial Cancer Survivors’ Perceptions of Provider Obesity Counseling and Attempted Behavior Change Are We Seizing the Moment? International Journal of Gynecological Cancer, 26(2), 318–324. https://doi.org/10.1097/IGC.0000000000000596
Deng, L., Feng, J., & Broaddus, R. R. (2010). The novel estrogen-induced gene EIG121 regulates autophagy and promotes cell survival under stress. Cell Death & Disease, 1(4), e32–e32. https://doi.org/10.1038/cddis.2010.9
Donkers, H., Fasmer, K. E., Mcgrane, J., Pijnenborg, J. M. A., Bekkers, R., Haldorsen, I. S., & Galaal, K. (2021). Obesity and visceral fat: Survival impact in high-grade endometrial cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology, 256, 425–432. https://doi.org/10.1016/j.ejogrb.2020.11.050
Endometrial cancer report | World Cancer Research Fund. (n.d.). https://www.wcrf.org/research-policy/library/endometrial-cancer-report/
Harvey, S. V, Wentzensen, N., Bertrand, K., Black, A., Brinton, L. A., Chen, C., Costas, L., Dal Maso, L., De Vivo, I., Du, M., Garcia-Closas, M., Goodman, M. T., Gorzelitz, J., Johnson, L., Lacey, J. V, Liao, L., Lipworth, L., Lissowska, J., Miller, A. B., … Clarke, M. A. (2023). Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2). International Journal of Epidemiology, 52(4), 1086–1099. https://doi.org/10.1093/ije/dyad046
Karataşlı, V., Can, B., Çakır, İ., Erkılınç, S., Kuru, O., Gökçü, M., & Sancı, M. (2021). Life quality of endometrioid endometrial cancer survivors: a cross-sectional study. Journal of Obstetrics and Gynaecology, 41(4), 621–625. https://doi.org/10.1080/01443615.2020.1787969
Koliaki, C., Dalamaga, M., & Liatis, S. (2023). Update on the Obesity Epidemic: After the Sudden Rise, Is the Upward Trajectory Beginning to Flatten? Current Obesity Reports, 12(4), 514–527. https://doi.org/10.1007/s13679-023-00527-y
Ladas, E. J., Sheng, H., Athale, U. H., Asselin, B. L., Clavell, L. A., Cole, P. D., Flamand, Y., Leclerc, J.-M., Laverdiere, C., Michon, B., Sallan, S. E., Silverman, L. B., Welch, J. J. G., Yao, S., & Kelly, K. M. (2025). Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia. JAMA Network Open, 8(5), e259952. https://doi.org/10.1001/jamanetworkopen.2025.9952
Lewin, S. N., Herzog, T. J., Medel, N. I. B., Deutsch, I., Burke, W. M., Sun, X., & Wright, J. D. (2010). Comparative Performance of the 2009 International Federation of Gynecology and Obstetricsʼ Staging System for Uterine Corpus Cancer. Obstetrics & Gynecology, 116(5), 1141–1149. https://doi.org/10.1097/AOG.0b013e3181f39849
Li, X., Yang, X., Cheng, Y., Dong, Y., Wang, J., & Wang, J. (2023). Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients. Journal of Gynecologic Oncology, 34(6). https://doi.org/10.3802/jgo.2023.34.e69
Makker, V., MacKay, H., Ray-Coquard, I., Levine, D. A., Westin, S. N., Aoki, D., & Oaknin, A. (2021). Endometrial cancer. Nature Reviews Disease Primers, 7(1), 88. https://doi.org/10.1038/s41572-021-00324-8
Marin, A.-G., Filipescu, A., & Petca, A. (2024). The Role of Obesity in the Etiology and Carcinogenesis of Endometrial Cancer. Cureus. https://doi.org/10.7759/cureus.59219
Mihm, M., Gangooly, S., & Muttukrishna, S. (2011). The normal menstrual cycle in women. Animal Reproduction Science, 124(3–4), 229–236. https://doi.org/10.1016/j.anireprosci.2010.08.030
Onstad, M. A., Schmandt, R. E., & Lu, K. H. (2016). Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. Journal of Clinical Oncology, 34(35), 4225–4230. https://doi.org/10.1200/JCO.2016.69.4638
Perry, R. J., & Shulman, G. I. (2020). Mechanistic Links between Obesity, Insulin, and Cancer. Trends in Cancer, 6(2), 75–78. https://doi.org/10.1016/j.trecan.2019.12.003
Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007). Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ, 335(7630), 1134. https://doi.org/10.1136/bmj.39367.495995.AE
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet, 371(9612), 569–578. https://doi.org/10.1016/S0140-6736(08)60269-X
Simancas-Racines, D., Campuzano-Donoso, M., Román-Galeano, N. M., Zambrano-Villacres, R., Memoli, P., Verde, L., Reytor-González, C., & Carbone, L. (2025). Obesity and endometrial cancer: biological mechanisms, nutritional strategies, and clinical perspectives. Food and Agricultural Immunology, 36(1). https://doi.org/10.1080/09540105.2025.2510961
Von Gruenigen, V. E., Courneya, K. S., Gibbons, H. E., Kavanagh, M. B., Waggoner, S. E., & Lerner, E. (2008). Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: A randomized trial. Gynecologic Oncology, 109(1), 19–26. https://doi.org/10.1016/j.ygyno.2007.12.026
- Downloads
- Additional Files
- Published
- 2025-10-18
- Section
- Research Article/Original Research
- Categories
- License
-
Copyright (c) 2025 Zainab Mohamed Alaa Alhelli, Amaal Mohammed Alhelli, Aadil S Aqabi

This work is licensed under a Creative Commons Attribution 4.0 International License.
